Caplin Point Laboratories has been selected under Forbes Asia’s 200 Best Under a Billion list for 2022. Forbes Asia has selected 200 best performing companies, with revenues of less than a billion, from a list of over 17,000 public listed companies across the Asia-Pacific.
Caplin Point has also been ranked 1 in India for “Most Consistent Profitable Growth across last 10 years” by Value Research magazine in the Wealth Insight June 2022 issue.
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
